Quoin Pharmaceuticals Ltd. Cash Flows From Used In Financing Activities
Quoin Pharmaceuticals Ltd. (QNRX) reported Cash Flows From Used In Financing Activities of -ILS 104.00 thousand for the 6-month period ending 2021-06-30, per its 6-K filed 2021-08-24.
Discontinued › Cash Flow › Financing Activities
ifrs-full:CashFlowsFromUsedInFinancingActivities · last filed 2021-08-24
ILS
| Period end | Cash Flows From Used In Financing Activities 6 month | Cash Flows From Used In Financing Activities 12 month |
|---|---|---|
| 2021-06-30 | -104.00K ILS 6-K · filed 2021-08-24 | |
| 2020-12-31 | 13.37M ILS 20-F · filed 2021-03-29 | |
| 2020-06-30 | 13.69M ILS 6-K · filed 2021-08-24 | |
| 2019-12-31 | 21.87M ILS 20-F · filed 2021-03-29 | |
| 2019-06-30 | 23.45M ILS 6-K/A · filed 2021-02-11 | |
| 2018-12-31 | 12.76M ILS 20-F · filed 2021-03-29 | |
| 2018-06-30 | 12.76M ILS 6-K · filed 2019-08-13 | |
| 2017-12-31 | 15.81M ILS 20-F · filed 2020-04-03 | |
| 2017-06-30 | 1.07M ILS 6-K · filed 2018-08-09 | |
| 2016-12-31 | 34.92M ILS 20-F · filed 2019-03-18 | |
| 2015-12-31 | 6.40M ILS 20-F · filed 2018-03-19 |
USD
| Period end | Cash Flows From Used In Financing Activities 6 month | Cash Flows From Used In Financing Activities 12 month |
|---|---|---|
| 2021-06-30 | -$32.00K 6-K · filed 2021-08-24 | |
| 2020-12-31 | $4.16M 20-F · filed 2021-03-29 | |
| 2019-12-31 | $6.33M 20-F · filed 2020-04-03 | |
| 2018-06-30 | $3.50M 6-K · filed 2018-08-09 | |
| 2017-12-31 | $4.56M 20-F · filed 2018-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 |